Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Meropenem (1000mg) + Tazobactum (125mg) Injection
Therapeutic Category
Antibacterials, Antibiotic
Dosage Form
Injection
Packaging Type
Vial
Packaging
1.125gm
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Merotyle TZ Injection is a potent combination of Meropenem (1000mg) and Tazobactam (125mg). Meropenem is a broad-spectrum carbapenem antibiotic that kills bacteria by inhibiting cell wall synthesis, while Tazobactam is a beta-lactamase inhibitor that protects Meropenem from degradation by resistant bacteria. This combination provides enhanced activity against a wide range of multidrug-resistant organisms.
It helps in the treatment of severe and hospital-acquired infections such as pneumonia, complicated urinary tract infections, intra-abdominal infections, skin and soft tissue infections, septicemia, and infections caused by resistant or mixed bacteria, particularly in critical care or ICU settings.
Common side effects may include pain or swelling at the injection site, diarrhea, headache, rash, nausea, or vomiting. Rarely, it may cause allergic reactions, seizures (especially in renal impairment), or liver/kidney function abnormalities.
Used to treat serious and complicated infections, especially those caused by resistant Gram-negative and Gram-positive bacteria. Effective in respiratory, urinary, intra-abdominal, and bloodstream infections, and often used in intensive care situations.
To be administered only under the supervision of a qualified healthcare provider. Inform your doctor if you have a history of epilepsy, kidney issues, or allergies to beta-lactam antibiotics. Complete the full course even if symptoms improve early.
Store below 25°C in a dry place, protected from light. Reconstituted solution should be used immediately or as advised by your healthcare professional. Keep out of reach of children.
Composition : Meropenem (1000mg) Injection
Composition : Meropenem (1000mg) + Sulbactam (500mg)
Composition : Meropenem (250mg)
Composition : Meropenem (500mg) Injection
Composition : Meropenem (125mg) Injection
Composition : Amoxycillin (125mg) + Clavulanic Acid (25mg)
Composition : Amoxycillin (250mg) + Clavulanic Acid (50mg)
Composition : Amoxycillin (500mg) + Clavulanic Acid (100mg)
Composition : Acetylcysteine B.P. 20% w/v 5ml
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Meropenem 1000 mg + Tazobactam 125 mg Injection is a broad-spectrum, high-end antibiotic combination used for severe and resistant bacterial infections such as pneumonia, sepsis, intra-abdominal infections, diabetic foot infections, and hospital-acquired infections. It is a critical-care injectable medicine widely used in ICUs, emergency departments, and surgical wards. It is a strong hospital and anti-infective segment product for medical distributors, wholesalers, and pharma franchise partners in the PCD pharma pharma franchise market.
Medical distributors and wholesalers can benefit from strong hospital demand and consistent institutional procurement, especially from ICUs, multispecialty hospitals, and surgical centers. Such advanced antibiotic combinations are commonly part of hospital treatment protocols, ensuring regular bulk orders and stable business flow.
Yes, Cafoli Lifecare offers PCD pharma pharma franchise opportunities in critical-care injectable and hospital antibiotic segments with monopoly rights, quality manufacturing standards, and reliable supply support for distributors and medical agencies.
Wholesalers and institutional suppliers benefit from high-value hospital orders, ICU-based prescriptions, and continuous demand in resistant infection management protocols, making it a stable and high-turnover segment when partnered with Cafoli Lifecare.
Medical distributors, stockists, and pharma professionals interested in hospital and critical-care antibiotic injectables can contact Cafoli Lifecare to discuss supply terms, product availability, and PCD pharma franchise opportunities in the injectable antibiotic segment.